Covered recipient · General Payments record
SANGITA K DOSHI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,281.95
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.45 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $148.75 | 3 |
| GlaxoSmithKline, LLC. | $61.21 | 4 |
| Astellas Pharma US Inc | $41.81 | 2 |
| Lilly USA, LLC | $26.00 | 1 |
| PFIZER INC. | $19.05 | 1 |
| Merck Sharp & Dohme Corporation | $15.48 | 1 |
| Novo Nordisk AS | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.81 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103655226 | CMS |
| ABBVIE INC. | $17.48 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103655228 | CMS |
| ABBVIE INC. | $112.46 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103655230 | CMS |
| Astellas Pharma US Inc | $19.89 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139372085 | CMS |
| Astellas Pharma US Inc | $21.92 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139421459 | CMS |
| GlaxoSmithKline, LLC. | $15.04 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116672526 | CMS |
| GlaxoSmithKline, LLC. | $15.87 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116720090 | CMS |
| GlaxoSmithKline, LLC. | $14.65 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115797325 | CMS |
| GlaxoSmithKline, LLC. | $15.65 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116732030 | CMS |
| Lilly USA, LLC | $26.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135415679 | CMS |
| Merck Sharp & Dohme LLC | $15.48 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141806867 | CMS |
| Novo Nordisk Inc | $13.15 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096972199 | CMS |
| PFIZER INC. | $19.05 | 12/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131115466 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.